A Randomized Controlled Study of Extracorporeal Photopheresis (ECP) Therapy with UVADEX® (Methoxsalen) for National Institutes of Health (NIH)-Graded Moderate to Severe Chronic Graft-Vs-Host Disease (cGVHD)

Madan Jagasia,Hildegard T Greinix,Christof Scheid,Gérard Socié,Francis A Ayuk,Johanna Tischer,Michele L Donato,Arpad Batai,Thomas Chin,Henri William Boodee,Ghaith Mitri

doi:10.1182/blood.v130.suppl_1.1970.1970

A Randomized Controlled Study of Extracorporeal Photopheresis (ECP) Therapy with UVADEX® (Methoxsalen) for National Institutes of Health (NIH)-Graded Moderate to Severe Chronic Graft-Vs-Host Disease (cGVHD)

Madan Jagasia, Hildegard T Greinix + Show 9 more

https://doi.org/10.1182/blood.v130.suppl_1.1970.1970

Copy DOI

Export

Save

Cite

Journal: Blood

Publication Date: Jun 25, 2021

Affiliation: Vanderbilt University, Medical University of Graz, University Hospital Cologne, Délégation Paris 7, University Medical Center Hamburg-Eppendorf, LMU Klinikum, Hackensack University Medical Center, Mallinckrodt (United States), Mallinckrodt (Ireland)

#Extracorporeal Photopheresis #Standard Of Care Arms #National Institutes Of Health Consensus Criteria #Extracorporeal Photopheresis Therapy #Standard Of Care #Speakers Bureau #Severe Subgroups #Total Skin Score #National Institutes Of Health Criteria #National Institutes Of Health

Abstract
Full-Text
Similar Papers

Abstract

Listen

A Randomized Controlled Study of Extracorporeal Photopheresis (ECP) Therapy with UVADEX® (Methoxsalen) for National Institutes of Health (NIH)-Graded Moderate to Severe Chronic Graft-Vs-Host Disease (cGVHD)

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Blood

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

A Randomized Controlled Study of Extracorporeal Photopheresis (ECP) Therapy with UVADEX® (Methoxsalen) for National Institutes of Health (NIH)-Graded Moderate to Severe Chronic Graft-Vs-Host Disease (cGVHD)